Does TOFACITINIB Cause Pustular psoriasis? 222 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 222 reports of Pustular psoriasis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
222
Reports of Pustular psoriasis with TOFACITINIB
0.1%
of all TOFACITINIB reports
150
Deaths
147
Hospitalizations
How Dangerous Is Pustular psoriasis From TOFACITINIB?
Of the 222 reports, 150 (67.6%) resulted in death, 147 (66.2%) required hospitalization, and 146 (65.8%) were considered life-threatening.
Is Pustular psoriasis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 222 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Pustular psoriasis?
ADALIMUMAB (685)
SECUKINUMAB (417)
METHOTREXATE (389)
ETANERCEPT (345)
INFLIXIMAB (326)
CERTOLIZUMAB PEGOL (310)
HYDROXYCHLOROQUINE (276)
USTEKINUMAB (276)
GOLIMUMAB (258)
LEFLUNOMIDE (245)
Which TOFACITINIB Alternatives Have Lower Pustular psoriasis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN